Journal
BIOCHEMICAL PHARMACOLOGY
Volume 212, Issue -, Pages -Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bcp.2023.115521
Keywords
DYRK1A; Diabetes; Neurological diseases; Cancers; Inhibitors
Categories
Ask authors/readers for more resources
DYRK1A is an evolutionarily conserved protein kinase and the most studied member of the DYRK family. It plays a role in the development of various diseases, and both low or high expression of DYRK1A protein can lead to disorder. It is recognized as a key target for therapy, and the studies on its natural and synthetic inhibitors have become increasingly popular.
Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) is an evolutionarily conserved protein kinase and the most studied member of the Dual-specificity tyrosine-regulated kinase (DYRK) family. It has been shown that it participates in the development of plenty of diseases, and both the low or high expression of DYRK1A protein could lead to disorder. Thus, DYRK1A is recognized as a key target for the therapy for these diseases, and the studies on natural or synthetic DYRK1A inhibitors have become more and more popular. Here, we provide a comprehensive review for DYRK1A from the structure and function of DYRK1A, the roles of DYRK1A in various types of diseases, including diabetes mellitus, neurodegenerative diseases, and kinds of cancers, and the studies of its natural and synthetic inhibitors.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available